OthonIliopoulosMD

Assistant Professor of Medicine, Massachusetts General Hospital

Dr. Iliopoulos is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
100 Blossom Street
Yaw 7 Massachusetts General Hospital
Boston, MA 02114
Phone+1 617-724-3404

Fax+1 617-726-8623

Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1992 - 1996
University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 1988 - 1992
Johns Hopkins UniversityFellowship, Allergy and Immunology, 1985 - 1988
University of AthensClass of 1985

PubMed

Belzutifan for patients with von Hippel-Lindau disease-associated CNS haemangioblastomas (LITESPARK-004): a multicentre, single-arm, phase 2 study.
Othon Iliopoulos, Ane B Iversen, Vivek Narayan, Benjamin L Maughan, Kathryn E Beckermann
The Lancet. Oncology. 2024-10-01
MITF regulates IDH1, NNT, and a transcriptional program protecting melanoma from reactive oxygen species.
Elisabeth Roider, Alexandra I T Lakatos, Alicia M McConnell, Poguang Wang, Alina Mueller
Scientific Reports. 2024-09-14
Belzutifan for von Hippel-Lindau Disease: Pancreatic Lesion Population of the Phase 2 LITESPARK-004 Study.
Tobias Else, Eric Jonasch, Othon Iliopoulos, Kathryn E Beckermann, Vivek Narayan
Clinical Cancer Research. 2024-05-01

Irp2 Regulates Insulin Production Through Iron-Mediated Cdkal1-Catalyzed tRNA ModificationJanuary 15th, 2020
DF/HCC Kidney Cancer Program Symposium 2016May 20th, 2016
Q&A with M. Celeste Simon, PhD, FAACR, on Advances in Kidney Cancer ResearchJune 17th, 2023